{"id":{"repo_id":"msu","oai_identifier":"oai:d.lib.msu.edu:etd_53253"},"canonical_url":"https://search.ndltd.org/etd/msu/oai:d.lib.msu.edu:etd_53253","repository":{"repo_id":"msu","name":"Michigan State University","base_url":"https://d.lib.msu.edu/oai"},"display":{"title":"NEXT GENERATION CANCER THERAPY : TUNABLE FLUORESCENT ORGANIC SALTS","abstract":"Thesis (Ph.D.)--Michigan State University. Cell and Molecular Biology - Doctor of Philosophy, 2026","abstract_html":"Thesis (Ph.D.)--Michigan State University. Cell and Molecular Biology - Doctor of Philosophy, 2026","abstract_has_math":false,"creators":["Roshanzadeh, Amir"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["Lunt, Sophia","Mahmoudi, Morteza","Henry, Ronald William","Lunt, Richard","Xiao, Hua"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2026,"date_issued":"2026","date_published":"2026","updated_at":"2026-11-18T18:59:44Z","subjects":["Cellular biology","Biochemistry","Molecular biology","Cytology"],"languages":["eng"],"rights":["Attribution-NonCommercial-NoDerivatives 4.0 International"],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:53253","local:Roshanzadeh_grad.msu_0128D_22300"],"render_values":[{"text":"etd:53253","href":null,"code":true},{"text":"local:Roshanzadeh_grad.msu_0128D_22300","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/doi:10.25335/zy4r-3k92","outbound_label":"DOI","outbound_source":"dc:identifier","record_url":"https://doi.org/doi:10.25335/zy4r-3k92","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://d.lib.msu.edu/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Ad.lib.msu.edu%3Aetd_53253","prefix":"oai_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Lunt, Sophia","Mahmoudi, Morteza","Henry, Ronald William","Lunt, Richard","Xiao, Hua"]},{"key":"dc:creator","label":"Author","values":["Roshanzadeh, Amir"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2026"]},{"key":"dc:relation","label":"Dc Relation","values":["Electronic Theses & Dissertations"]},{"key":"dc:type","label":"Dc Type","values":["text","Electronic dissertations"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Cellular biology","Biochemistry","Molecular biology","Cytology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["Attribution-NonCommercial-NoDerivatives 4.0 International"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:53253","local:Roshanzadeh_grad.msu_0128D_22300","https://doi.org/doi:10.25335/zy4r-3k92"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Thesis (Ph.D.)--Michigan State University. Cell and Molecular Biology - Doctor of Philosophy, 2026","Cancer remains a leading cause of morbidity and mortality worldwide, and despite substantial advances in surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy, many treatment regimens remain limited by off-target toxicity, incomplete tumor control, disease recurrence, and long-term impairment of normal tissue function. These limitations underscore the need for therapeutic strategies that improve precision while minimizing collateral damage to healthy tissues. Photodynamic therapy (PDT) is a minimally invasive treatment modality that combines a photosensitizer (PS), light, and molecular oxygen to generate reactive oxygen species (ROS) that induce localized tumor destruction. Because many PSs are also fluorescent, they can function as theranostic agents with utility in both cancer imaging and therapy. However, the broader clinical implementation of PDT has been constrained by the limitations of conventional PSs, including poor tumor selectivity, limited tissue penetration, prolonged photosensitivity, dark toxicity, and suboptimal pharmacologic behavior. These challenges have motivated the development of next-generation photoactive agents with improved optical, electronic, and biologic properties.This dissertation develops a tunable platform of near-infrared (NIR) cyanine-based organic salts for cancer imaging and photodynamic therapy. By pairing a photoactive heptamethine cyanine cation with chemically distinct, non-photoactive counterions, this platform enables modulation of phototoxicity and biologic behavior while preserving the favorable optical properties of the cyanine scaffold. In particular, carborane-based counterions provide a strategy to refine therapeutic performance through counterion engineering. These fluorescent organic salts self-assemble into nanoparticles and can be designed to exhibit low toxicity for imaging or selective phototoxicity for therapy. This dissertation first establishes the scientific foundation for this work by reviewing current challenges in cancer treatment, the principles of PDT, and the evolution of photosensitizer development. It then examines the design, characterization, and biologic activity of cyanine–carborane photosensitizers as next-generation photoactive agents with tunable therapeutic potential. Using cellular and preclinical cancer models, this work demonstrates that rational counterion pairing can substantially influence dark toxicity, light-activated cytotoxicity, and overall therapeutic performance. Optimized cyanine–carborane photosensitizers exhibit favorable tumor-associated behavior, retain NIR fluorescence, and produce strong photodynamic antitumor effects without evidence of major systemic toxicity. The dissertation further extends this platform to head and neck squamous cell carcinoma models, where differential responses to PDT demonstrate that tumor context influences therapeutic outcome and emphasize the importance of understanding determinants of sensitivity to next-generation PDT agents. Collectively, these studies establish cyanine–carborane organic salts as a versatile and rationally tunable platform for cancer phototheranostics and support their broader translational potential as a more precise strategy for cancer treatment.","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf","1 online resource (303 p.) : ill."]},{"key":"dc:title","label":"Title","values":["NEXT GENERATION CANCER THERAPY : TUNABLE FLUORESCENT ORGANIC SALTS"]}]}],"canonical_facts":{"dc:contributor":["Lunt, Sophia","Mahmoudi, Morteza","Henry, Ronald William","Lunt, Richard","Xiao, Hua"],"dc:creator":["Roshanzadeh, Amir"],"dc:date":["2026"],"dc:description":["Thesis (Ph.D.)--Michigan State University. Cell and Molecular Biology - Doctor of Philosophy, 2026","Cancer remains a leading cause of morbidity and mortality worldwide, and despite substantial advances in surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy, many treatment regimens remain limited by off-target toxicity, incomplete tumor control, disease recurrence, and long-term impairment of normal tissue function. These limitations underscore the need for therapeutic strategies that improve precision while minimizing collateral damage to healthy tissues. Photodynamic therapy (PDT) is a minimally invasive treatment modality that combines a photosensitizer (PS), light, and molecular oxygen to generate reactive oxygen species (ROS) that induce localized tumor destruction. Because many PSs are also fluorescent, they can function as theranostic agents with utility in both cancer imaging and therapy. However, the broader clinical implementation of PDT has been constrained by the limitations of conventional PSs, including poor tumor selectivity, limited tissue penetration, prolonged photosensitivity, dark toxicity, and suboptimal pharmacologic behavior. These challenges have motivated the development of next-generation photoactive agents with improved optical, electronic, and biologic properties.This dissertation develops a tunable platform of near-infrared (NIR) cyanine-based organic salts for cancer imaging and photodynamic therapy. By pairing a photoactive heptamethine cyanine cation with chemically distinct, non-photoactive counterions, this platform enables modulation of phototoxicity and biologic behavior while preserving the favorable optical properties of the cyanine scaffold. In particular, carborane-based counterions provide a strategy to refine therapeutic performance through counterion engineering. These fluorescent organic salts self-assemble into nanoparticles and can be designed to exhibit low toxicity for imaging or selective phototoxicity for therapy. This dissertation first establishes the scientific foundation for this work by reviewing current challenges in cancer treatment, the principles of PDT, and the evolution of photosensitizer development. It then examines the design, characterization, and biologic activity of cyanine–carborane photosensitizers as next-generation photoactive agents with tunable therapeutic potential. Using cellular and preclinical cancer models, this work demonstrates that rational counterion pairing can substantially influence dark toxicity, light-activated cytotoxicity, and overall therapeutic performance. Optimized cyanine–carborane photosensitizers exhibit favorable tumor-associated behavior, retain NIR fluorescence, and produce strong photodynamic antitumor effects without evidence of major systemic toxicity. The dissertation further extends this platform to head and neck squamous cell carcinoma models, where differential responses to PDT demonstrate that tumor context influences therapeutic outcome and emphasize the importance of understanding determinants of sensitivity to next-generation PDT agents. Collectively, these studies establish cyanine–carborane organic salts as a versatile and rationally tunable platform for cancer phototheranostics and support their broader translational potential as a more precise strategy for cancer treatment.","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."],"dc:format":["application/pdf","1 online resource (303 p.) : ill."],"dc:identifier":["etd:53253","local:Roshanzadeh_grad.msu_0128D_22300","https://doi.org/doi:10.25335/zy4r-3k92"],"dc:language":["eng"],"dc:relation":["Electronic Theses & Dissertations"],"dc:rights":["Attribution-NonCommercial-NoDerivatives 4.0 International"],"dc:subject":["Cellular biology","Biochemistry","Molecular biology","Cytology"],"dc:title":["NEXT GENERATION CANCER THERAPY : TUNABLE FLUORESCENT ORGANIC SALTS"],"dc:type":["text","Electronic dissertations"]},"updated_at":"2026-11-18T18:59:44Z"}